News and updates
May 11, 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”
April 27, 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital
January 10, 2023
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs
December 8, 2022
Ansbert Gadicke- Discusses the role of Innovation in Biotech
August 25, 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
August 16, 2022
Orna Therapeutics: circular logic
August 16, 2022
BioImpact Capital, an MPM affiliate, Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer
August 16, 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
August 16, 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic
June 2, 2022
Chris Bardon Interview (GBR Capital)
May 11, 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”
May 11, 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”